Structural Formula (Bum02 0000 01)
Bumetanide Injection, Solution
Product Images NDC 25021-321
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 25021-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Vial Label (Bum02 0000 02)
This is a single-dose vial of Bumelcn de Injection, USP containing 1 mg per 4mL (0.25 mg per mL) for intravenous or intramuscular use. It also contains Benzyl Alcohol and is marked with the unique code (01)00325021321041.*
Package Label – Principal Display Panel – Vial Label (Bum02 0000 03)
This text provides information about Bumetanide, which is available in a 2.5 mg per 10 mL solution (0.25 mg per mL). It is specified for intravenous or intramuscular use and contains Benzyl Alcohol. The specifics mention a 10 mL Multi-Dose Vial with an unvarnished area of 20 x 12 mm.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
